Those looking for a more comprehensive, customized hair care solution may want to explore alternative brands
Have recommended it to friends
In a 68-week clinical trial, patients treated with GLP-1 experienced an average weight loss of 14.9% from their initial body Trusted Source Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial Rubino D, Abrahamsson N, Davies M, et al Go to Source weight
We treat them as tools that may support a patient who needs medical help with weight loss, especially when appetite regulation, consistency, and obesity-related risks are already part of the problem
The studies are correlative, but appear to show that the drugs not only reverse the carcinogenic risks that come with obesity, they may also have additional anti-inflammatory effects that help suppress tumors